Efficacy of pegylated interferon α2a in patients without HBeAg loss after the withdrawal of long-term lamivudine therapy

BACKGROUND: Improving the HBe seroconversion rate of patients without HBeAg loss after long-term lamivudine therapy has become an urgent clinical problem that we have to face. Unfortunately, there is no consensus on the mananement of these patients. The aim of this study was to evaluate the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xu-Qing, Zhang, Hui-Yan, You, Jian-Ping, Mao, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698159/
https://www.ncbi.nlm.nih.gov/pubmed/23320822
http://dx.doi.org/10.1186/1743-422X-10-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698159/
https://www.ncbi.nlm.nih.gov/pubmed/23320822
http://dx.doi.org/10.1186/1743-422X-10-21

Ejemplares similares